Academic Training in Hematology

血液学学术培训

• 批准号: 8551020
• 负责人: VICTOR JACK MARDER
• 金额: $ 26.65万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-07-01 至 2018-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8551020
• 关键词: Academic Training; Hematology

DESCRIPTION (provided by applicant): This is a resubmission of a competitive renewal application for a PHS Institutional National Service Award (T32 HL66992) at the David Geffen School of Medicine at UCLA to prepare post-doctoral fellows for an academic career in Hematology. This award was initiated in July, 2002, and supports 4 fellowship slots in years 2 and 3 of Hematology/Medical Oncology training. The Program Director is Victor Marder, MD, and the Associate Program Director is Donald Kohn, MD. In keeping with the NHLBI mission for training fellows in non-malignant hematology, we have made significant changes in our program regarding leadership, research foci, and selection of and funding of fellows for their research years of training. Of note are 1) the appointment of a pediatric hematology fellow who will study gene transplantation in sickle cell disease, 2) the elimination of an existing research focus in Leukemia, and 3) re-organization of Training Grant leadership to reflect our focus on non-malignant hematology. Since 2002, 22 fellows have completed their fellowship at UCLA, 15 of which (68%) are actively involved in research, 12 (55%) as full-time faculty at a University or Medical Center or in a full-time research position in industry, and 3 with active clinical research programs as part of their practice, including 2 who have voluntary university appointments. In the last 3 years (2010-2012), 7 of 8 graduates (87.5%) entered full- or part-time university or industry positions of research. All fellows entering the program are Training Grant Eligible (TGE). The faculty consists of 31 academic scientists and physicians, 89% of whom have NIH grant funding, grouped into 3 research foci, Hematopoiesis and Stem Cell Biology (Don Kohn, MD, Director), Lymphocyte Biology (John Timmerman, MD, Director) and Coagulation and Vascular Biology (Victor Marder, MD, Director). Interaction with other training programs in complementary disciplines, notably those in the Broad Stem Cell Research Center, the T32 Training Grant in Developmental Hematology, and the NCI T32 Training Grant in Medical Oncology, emphasizes the resources available to meet our mission of basic and translational research careers. A core curriculum is offered to all fellows, including a "Clinical Research Course", which covers subjects on research design and analysis, ethics, regulatory issues, grant preparation and responsible conduct of research. Fellows are encouraged to obtain an advanced degree as part of the STAR program, and 2 have obtained the Master's degree and 2 a PhD degree. Formal review of the mentor's effectiveness and the fellow's achievements are prepared by the Steering Committee, made up of the 3 Focus Directors, the PI of the Division Oncology Training Grant (Antoni Ribas, MD, PhD), and the Director of the Division Fellowship Training Program (Arash Naeim, MD, PhD). Three research retreats are held each year, fall retreats at which first year research proposals are proposed and second year progress reports are reviewed, and a spring retreat for final reports of graduating fellows. We are proud of our success in training underrepresented Minority candidates, 3 of 13 (23%) since 2007 being Hispanic or African-American.

描述（由申请人提供）：这是在加州大学洛杉矶分校的David Geffen医学院的PHS机构国家服务奖（T32 HL66992）的竞争性更新申请的重新提交，以准备医生后的研究员为血液学学术生涯。该奖项于2002年7月启动，并在血液学/医学肿瘤学培训的第2年和第3年中支持4个奖学金老虎机。该计划主管是医学博士Victor Marder，副计划主任是医学博士Donald Kohn。为了符合NHLBI在非恶性血液学领域的培训研究员的任务，我们在计划，研究重点以及对研究员的研究年度培训的计划中进行了重大更改。值得注意的是1）任命将研究镰状细胞病中基因移植的小儿血液学研究员，2）消除白血病中现有的研究重点，以及3）重组培训赠款领导力，以反映我们对非恶性血液学的重点。自2002年以来，有22名研究员在UCLA完成了奖学金，其中15名（68％）积极参与研究，有12名（55％）作为大学或医学中心的全日制教职 作为他们实践的一部分计划，其中包括有2名自愿任命的计划。在过去的3年（2010-2012）中，有8位毕业生中有7名（87.5％）进入了全日制或兼职的大学或行业研究职位。进入该计划的所有研究员均为培训授予资格（TGE）。 The faculty consists of 31 academic scientists and physicians, 89% of whom have NIH grant funding, grouped into 3 research foci, Hematopoiesis and Stem Cell Biology (Don Kohn, MD, Director), Lymphocyte Biology (John Timmerman, MD, Director) and Coagulation and Vascular Biology (Victor Marder, MD, Director).与互补学科中的其他培训计划的互动，特别是在广泛的干细胞研究中心，发育血液学中的T32培训补助金以及医学肿瘤学中NCI T32培训赠款的互动，强调了实现我们的基本和翻译研究职业的使命。为所有研究员提供核心课程，包括“临床研究课程”，该课程涵盖了研究设计和分析，道德，监管问题，授予准备和负责任的研究的主题。鼓励研究员作为Star计划的一部分获得高级学位，2获得了硕士学位和2 a博士学位。对导师的有效性和同伴的成就的正式审查是由指导委员会准备的，由3个焦点主管，部门肿瘤学培训补助金（Antoni Ribas，MD，PhD）组成，以及部门奖学金培训计划（Arash Naeim，MD，MD，PhD）的主任。每年进行三项研究务虚会，秋季务虚会提出了第一年的研究建议，并审查了第二年的进度报告，并进行了春季务虚会，以供毕业的研究员进行最终报告。我们为我们在培训代表性不足的少数民族候选人方面的成功而感到自豪，自2007年以来，有13名（23％）中有3名是西班牙裔或非裔美国人。